Back to today’s briefing

Story perspectives

Blood Test Identifies Alzheimer's Risk, Offers Hope

6/24/2025

46 10

Summary

University Study Uncovers

A groundbreaking study from the University of Brescia reveals that a simple blood test for insulin resistance can pinpoint early Alzheimer’s patients facing a staggering fourfold risk of swift cognitive decline. Unveiled at the European Academy of Neurology Congress, this research opens the door to innovative strategies aimed at combating the disease by addressing metabolic dysfunction.

Summary

Biomarkers Bridge Disparities

Plasma biomarkers like p-tau231 and p-tau217 are emerging as crucial tools in diagnosing and tracking Alzheimer's disease. However, disparities in biomarker eligibility for clinical trials reveal a troubling gap among racial and ethnic groups. Meanwhile, innovative blood tests like PrecivityAD2 are paving the way for earlier detection of amyloid and potential cognitive decline.

1 of 2

University Study Uncovers

A groundbreaking study from the University of Brescia reveals that a simple blood test for insulin resistance can pinpoint early Alzheimer’s patients facing a staggering fourfold risk of swift cognitive decline. Unveiled at the European Academy of Neurology Congress, this research opens the door to innovative strategies aimed at combating the disease by addressing metabolic dysfunction.

1 / 2